In vitro therapy against glioblastoma cells by 3-Dezaneplanocin-A, panobinostat, and temozolomide
Background: Glioblastoma multiforme (GBM) is the most malignant primary brain tumor. Current treatment against this tumor consists of maximal surgical resection without threatening the patient's life, followed by a treatment with temozolomide, with or without combined radiotherapy. GBM is resistant...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wolters Kluwer Medknow Publications
2018-01-01
|
| Schriftenreihe: | Glioma |
| Schlagworte: | |
| Online-Zugang: | http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=1;spage=22;epage=26;aulast=de |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
